APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study.

M I E van PoelgeestKim E Kortekaas H Lena C van DoornMaaike OonkHans W NijmanIngrid A BoereAnneke L EerkensAnn ReynersPatricia C Ewing-GrahamJoost BartTjalling BosseMarij J P WeltersJudith R KroepSjoerd H van der Burg

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

NCT05761132.

Keyphrases

phase ii
squamous cell carcinoma
clinical trial
open label
double blind
early stage
placebo controlled
phase iii
advanced non small cell lung cancer
sentinel lymph node
cross sectional
randomized controlled trial
lymph node metastasis
lymph node
rectal cancer